Novo Nordisk Aktie
39,21
EUR
+0,89
EUR
+2,32
%
39,32
EUR
+0,79
EUR
+2,05
%
Werbung
Novo Nordisk Aktie Analyse
| 02.05.24 | Novo Nordisk Neutral | UBS AG | |
| 02.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.05.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 13.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.09.23 | Novo Nordisk Overweight | Barclays Capital | |
| 07.09.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.09.23 | Novo Nordisk Sell | UBS AG | |
| 05.09.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
|
Werbung
|
|||
| 05.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.09.23 | Novo Nordisk Overweight | Barclays Capital | |
| 30.08.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 21.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 15.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 11.08.23 | Novo Nordisk Sell | UBS AG | |
| 11.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 10.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.08.23 | Novo Nordisk Sell | UBS AG | |
| 08.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 08.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.07.23 | Novo Nordisk Sell | UBS AG | |
| 12.07.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.07.23 | Novo Nordisk Outperform | Credit Suisse Group | |
| 05.07.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.06.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.06.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 27.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 26.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.06.23 | Novo Nordisk Sell | UBS AG | |
| 20.06.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.06.23 | Novo Nordisk Sell | UBS AG | |
| 12.06.23 | Novo Nordisk Sell | UBS AG | |
| 08.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 26.05.23 | Novo Nordisk Sell | UBS AG | |
| 23.05.23 | Novo Nordisk Overweight | Barclays Capital | |
| 23.05.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 22.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 22.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.05.23 | Novo Nordisk Buy | Deutsche Bank AG | |
Werbung
Werbung